Hepatitis C: An In-Depth Guide


Prescription Drug Programs in Yukon

General information on drug coverage and benefit programs offered by the provincial, territorial and federal governments can be found here.

Registered First Nations and recognized Inuit people are able to access coverage for their hepatitis C medications through the Non-Insured Health Benefits (NIHB) program. NIHB is a federal program that provides eligible First Nations and Inuit people with coverage for many prescription drugs and health services.  People can contact NIHB by phone or mail at:

Non-Insured Health Benefits – Yukon Region
First Nations and Inuit Health
Health Canada
300 Main Street, Suite 100
Whitehorse, Yukon
Y1A 2B5                                                                                                                    

Toll-free: 1-866-362-6717

Coverage for Hepatitis C Medications

In Yukon, hepatitis specialists or nurses can apply, on their patient’s behalf, for drug benefits from the Chronic Disease Program. This program is designed to assist people with chronic diseases, including hepatitis C, by providing them with financial assistance to cover the cost of their medications. For Social Assistance recipients, the cost of hepatitis C medications is automatically covered by this program.

The Yukon drug formulary outlines hepatitis C medications that are eligible for coverage.

There are no restrictions on access to treatment based on level of liver injury (fibrosis stage) in Yukon. Some other jurisdictions still have restrictions on who qualifies for treatment coverage based on fibrosis level.

If people would like more information about Pharmacare, the Chronic Disease Program or the Children’s Drug and Optical Program, they can call 1-867-667-5092.


Costs and Coverage for Treatment in Canada

Some programs can be accessed by all Canadians. Examples include:

Private health insurance

Some health insurance policies offered through private insurance companies include coverage for prescription drugs. These programs often have their own deductible, or co-pay fee, and may have yearly maximums for prescription drugs.

Programs offered by pharmaceutical companies

The pharmaceutical companies that make Hep C medications have programs to help people complete treatment.

These programs have phone support for people on treatment, and part of this support is helping people to access the funding necessary to cover treatment costs. These programs can inform patients about local, provincial, and federal government programs for accessing treatment and can help the patient find out ways to maximize any public funding or private medical insurance (including the appeals process, if the patient also has a supportive doctor). If a person is eligible, some programs can help cover the insurance company co-pay fee, provincial or territorial plan's deductible, and a number of other expenses, depending on a person's specific situation.

AbbVie has the AbbVie Care Program for people taking Holkira Pak (dasabuvir, ombitasvir, paritaprevir and ritonavir) or Maviret (glecaprevir and pibrentasvir). Bristol-Myers Squibb Canada has the CLAIRE Program for people taking Daklinza (daclatasvir). Gilead Sciences has the Momentum HCV Support Program for people taking Epclusa (sofosbuvir and velpatasvir), Harvoni (sofosbuvir and ledipasvir), Sovaldi (sofosbuvir) or Vosevi (sofosbuvir, velpatasvir and voxilaprevir). Merck has the Merck Care Hepatitis Program for people taking Zepatier (elbasvir and grazoprevir).

For more information, contact:

 Merck Care Program


 Momentum Support Program (Gilead)


AbbVie Care 


CLAIRE Program (Bristol-Myers Squibb Canada)


People who contracted hepatitis C from a blood transfusion between 1986 and 1990 may be eligible to have hepatitis C treatment expenses covered by the Hepatitis C January 1, 1986 - July 1, 1990 Class Actions Settlement. To learn more about these programs, see Compensation.

Revised 2018.